Email updates

Keep up to date with the latest news and content from BMC Proceedings and BioMed Central.

This article is part of the supplement: International Conference on Prevention & Infection Control (ICPIC 2011)

Open Access Oral presentation

Can the application of the international health regulations to antimicrobial resistance events help to preserve antimicrobials?

D Wernli1, T Haustein2*, J Conly2 and S Harbarth2

  • * Corresponding author: T Haustein

Author Affiliations

1 Division of International and Humanitarian Medicine, University of Geneva Hospitals and Faculty of Medicine, Geneva, Switzerland

2 Infection Control Program, University of Geneva Hospitals and Faculty of Medicine, Geneva, Switzerland

For all author emails, please log on.

BMC Proceedings 2011, 5(Suppl 6):O40  doi:10.1186/1753-6561-5-S6-O40

The electronic version of this article is the complete one and can be found online at:

Published:29 June 2011

© 2011 Wernli et al; licensee BioMed Central Ltd.

This is an open access article distributed under the terms of the Creative Commons Attribution License (, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Introduction / objectives

The global threat of antimicrobial resistance (AMR) needs to be addressed urgently. The global surveillance of AMR pathogens is patchy and limited by financial and technical constraints. Without an early-warning system, the emergence and spread of AMR often goes unnoticed until a given strain has become endemic.


Using the example of carbapenem-resistant Enterobacteriaceae (CRE), we analyzed the potential role of the International Health Regulations (IHR), a legally binding agreement between 194 States Parties, whose aim is “to prevent, protect against, control and provide a public health response to the international spread of disease” with respect to AMR and assess whether selected CRE events fulfil the four criteria of Annex 2 of the IHR.


Certain events marking the emergence and international spread of KPC and NDM-1-producing CRE fulfil the criteria for notifiability to WHO. This can be extrapolated to other types of AMR. At the same time, ambiguities in Annex 2 and limited specific WHO guidance may make notification decisions a matter of debate. Obstacles for the application of the IHR to AMR include a lack of capacities within WHO.


The global threat posed by the spread of AMR requires a coordinated international response. Recognizing the applicability of the IHR to AMR could serve as a “wake-up call” and obligate WHO and States Parties to strengthen surveillance and response, which could in turn contribute to containing the spread of AMR and preserve the efficacy of antimicrobials. Although States Parties and WHO share a collective responsibility in the process, WHO must clearly delineate its position regarding AMR and the intended role of the IHR in this context.

Disclosure of interest

None declared.